Kingstone Companies, Inc. (NASDAQ:KINS – Get Rating)’s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.52 and traded as low as $1.68. Kingstone Companies shares last traded at $1.70, with a volume of 24,180 shares traded.
Analyst Upgrades and Downgrades
Separately, Piper Sandler upped their price objective on Kingstone Companies from $3.50 to $3.75 in a research report on Tuesday, January 10th.
Kingstone Companies Stock Up 0.6 %
The stock has a market cap of $18.10 million, a PE ratio of -1.10 and a beta of 0.40. The firm has a fifty day moving average of $1.34 and a 200 day moving average of $2.52. The company has a quick ratio of 0.45, a current ratio of 0.45 and a debt-to-equity ratio of 0.77.
Hedge Funds Weigh In On Kingstone Companies
Several large investors have recently bought and sold shares of KINS. Family Management Corp acquired a new position in Kingstone Companies in the third quarter valued at $27,000. Advisor Group Holdings Inc. boosted its stake in Kingstone Companies by 11.7% in the first quarter. Advisor Group Holdings Inc. now owns 63,661 shares of the insurance provider’s stock valued at $339,000 after acquiring an additional 6,679 shares in the last quarter. Finally, New England Asset Management Inc. acquired a new position in Kingstone Companies in the third quarter valued at $398,000. Hedge funds and other institutional investors own 46.13% of the company’s stock.
About Kingstone Companies
Kingstone Cos., Inc operates as a holding company, which engages in the provision of property and casualty insurance policies to individuals and small businesses through its subsidiary. Its writing business are carried through independent retail and wholesale agents and brokers. The company was founded in 1886 and is headquartered in Kingston, NY.
Read More
- Get a free copy of the StockNews.com research report on Kingstone Companies (KINS)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Kingstone Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kingstone Companies and related companies with MarketBeat.com's FREE daily email newsletter.